Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Insulin-like growth factor-1 (IGF-1) given peripherally has been found effective in clinical trials to slow down neuronal degeneration in some nervous system diseases. This raises the question of whether and how IGF-1 crosses the blood-brain barrier (BBB). In this report, we found that IGF-1 had a half-life of 4.5 min in blood, could remain intact for 20 min, and entered brain and spinal cord linearly. In the brain, IGF-1 had an influx rate of 0.4 µl/g·min after intravenous (iv) bolus injection as determined by multiple-time regression analysis. Intact radiolabeled IGF-1 was present in brain at 20 min after iv injection. Most of the injected IGF-1 entered the brain parenchyma instead of being entrapped in the cerebral vasculature. Addition of nonradiolabeled IGF-1 enhanced the influx of radiolabeled IGF-1 after iv injection, but inhibited the influx of radiolabeled IGF-1 by in-situ brain perfusion, suggesting that protein binding can explain the difference between the iv and perfusion experiments. In the spinal cord, the cervical region had the fastest uptake, followed by lumbar spinal cord. The thoracic spinal cord had the slowest uptake, comparable to that of brain. By contrast, des(1-3)IGF-1, an IGF-1 analogue with little protein binding but similar biological activity, had a shorter half-life in blood, slower influx rate into brain, and no alteration in pharmacokinetics after addition of nonradiolabeled peptide. We conclude that IGF-1 enters the CNS by a saturable transport system at the BBB, which functions in synchrony with IGF binding proteins in the periphery to regulate the availability of IGF-1 to the CNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, since IGF-1 can readily pass the blood-brain barrier (Pan and Kastin 2000) in contrast to BDNF, its effects on the brain can be achieved by direct injection into the blood.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pan and Kastin 2000
Citations
Cites
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Poduslo, J. F., & Curran, G. L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00250-v · Cited by 614
Insulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/en.135.5.1753 · Cited by 391
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
Insulin-Like Growth Factor Binding Proteins in the Human Circulation: A Review
Baxter, R. C. (1994) · Hormone Research · doi:10.1159/000184186 · Cited by 345
Permeability of the blood–brain barrier to neurotrophins
Pan, W., Banks, W. A., & Kastin, A. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01525-4 · Cited by 181
Self-citation(1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01036-3 · Cited by 177
Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders
Lewis, M. E., Neff, N. T., Contreras, P. C., Stong, D. B., Oppenheim, R. W., Grebow, P. E., & Vaught, J. L. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1177 · Cited by 169
Human blood-brain barrier insulin-like growth factor receptor
Duffy, K. R., Pardridge, W. M., & Rosenfeld, R. G. (1988) · Metabolism · doi:10.1016/s0026-0495(98)90007-5 · Cited by 158
Passage of peptides across the blood-brain barrier: Pathophysiological perspectives
Banks, W. A., & Kastin, A. J. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00380-3 · Cited by 120
Self-citation
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Lichtenwalner, R. J., Forbes, M. E., Bennett, S. A., Lynch, C. D., Sonntag, W. E., & Riddle, D. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00378-5 · Cited by 428
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Cytokine Signaling Modulates Blood-Brain Barrier Function
Pan, W., P. Stone, K., Hsuchou, H., K. Manda, V., Zhang, Y., & J. Kastin, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798220918 · Cited by 241
“Insulin-like growth factor (IGF)-1 also is transported across the BBB [75], and its transport system is not identical to that transporting insulin although there is partial sharing [76].”
BackgroundSelf-citationBiological hypotheses and biomarkers of bipolar disorder
Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 235
Growth hormone and cognitive function
Nyberg, F., & Hallberg, M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.78 · Cited by 235
Chavez, J. C., & LaManna, J. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08922.2002 · Cited by 231
Differential BBB interactions of three ingestive peptides: Obestatin, ghrelin, and adiponectin
Pan, W., Tu, H., & Kastin, A. J. (2006) · Peptides · doi:10.1016/j.peptides.2005.12.014 · Cited by 226
Self-citationThe Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging
Vecchio, L. M., Meng, Y., Xhima, K., Lipsman, N., Hamani, C., & Aubert, I. (2018) · Brain Plasticity · doi:10.3233/bpl-180069 · Cited by 225
C-Reactive Protein Increases BBB Permeability: Implications for Obesity and Neuroinflammation
Hsuchou, H., Kastin, A. J., Mishra, P. K., & Pan, W. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343302 · Cited by 187
Self-citationIGF-1 in the Brain as a Regulator of Reproductive Neuroendocrine Function
Daftary, S. S., & Gore, A. C. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000503 · Cited by 180
Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction
Cefis, M., Chaney, R., Wirtz, J., Méloux, A., Quirié, A., Leger, C., Prigent‐Tessier, A., & Garnier, P. E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1275924 · Cited by 166
On the Run for Hippocampal Plasticity
Cooper, C., Moon, H. Y., & van Praag, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029736 · Cited by 159
Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier
Pan, W., Kastin, A. J., Zankel, T. C., van Kerkhof, P., Terasaki, T., & Bu, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01381 · Cited by 153
Self-citationKooijman, R., Sarre, S., Michotte, Y., & De Keyser, J. (2009) · Stroke · doi:10.1161/strokeaha.108.528356 · Cited by 152
Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly
Denti, L., Annoni, V., Cattadori, E., Salvagnini, M. A., Visioli, S., Merli, M. F., Corradi, F., Ceresini, G., Valenti, G., Hoffman, A. R., et al. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.049 · Cited by 132
Duman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
“Saturable transport of IGF-I at the blood–brain-barrier and megalinmediated transport of IGF-I in the choroids plexus have been reported [10,39,43].”
BackgroundWang, L., Shansky, J., Borselli, C., Mooney, D., & Vandenburgh, H. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0663 · Cited by 120
Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review
Frater, J., Lie, D., Bartlett, P., & McGrath, J. J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.002 · Cited by 120
Mitschelen, M., Yan, H., Farley, J. A., Warrington, J. P., Han, S., Hereñú, C. B., Csiszar, A., Ungvari, Z., Bailey-Downs, L. C., Bass, C. E., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.032 · Cited by 103
“, 2009), despite studies indicating that IGF-1 can cross the blood brain barrier (Armstrong et al., 2000; Carro et al., 2005; Pan and Kastin, 2000; Yu et al., 2006).”
Whiteman, A. S., Young, D. E., He, X., Chen, T. C., Wagenaar, R. C., Stern, C. E., & Schon, K. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.023 · Cited by 102
Andrade e Silva, B., Cassilhas, R. C., Attux, C., Cordeiro, Q., Gadelha, A. L., Telles, B. A., Bressan, R. A., Ferreira, F. N., Rodstein, P. H., Daltio, C. S., et al. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1595 · Cited by 94
The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
Costales, J., & Kolevzon, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.001 · Cited by 93
Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia
Maurus, I., Hasan, A., Röh, A., Takahashi, S., Rauchmann, B., Keeser, D., Malchow, B., Schmitt, A., & Falkai, P. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01025-w · Cited by 81
Miao, J., Zhang, Y., Chen, S., Zheng, Q., & Guo, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04457-1 · Cited by 80
Wang, Y., Wang, W., Li, D., Li, M., Wang, P., Wen, J., Liang, M., Su, B., & Yin, Y. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24607 · Cited by 79
Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action
Muzumdar, R. H., Ma, X., Fishman, S., Yang, X., Atzmon, G., Vuguin, P. M., Einstein, F. H., Hwang, D., Cohen, P., & Barzilai, N. (2006) · Diabetes · doi:10.2337/db06-0318 · Cited by 78
Toth, L., Czigler, A., Hegedus, E., Komaromy, H., Amrein, K., Czeiter, E., Yabluchanskiy, A., Koller, A., Orsi, G., Perlaki, G., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00623-2 · Cited by 77
Inflammation at birth and the insulin‐like growth factor system in very preterm infants
Hansen‐Pupp, I., Hellström-Westas, L. K., Cilio, C., Andersson, S., Fellman, V., & Ley, D. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00276.x · Cited by 77
Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence
Yan, H., Mitschelen, M., Bixler, G. V., Brucklacher, R. M., Farley, J. A., Han, S., Freeman, W. M., & Sonntag, W. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0200 · Cited by 72
Hung, K.-S., Tsai, S., Lee, T.-C., Lin, J., Chang, C.-K., & Chiu, W. (2007) · Journal of Neurosurgery Spine · doi:10.3171/spi.2007.6.1.35 · Cited by 72
Grevès, M. L., Grevès, P. L., & Nyberg, F. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.01.012 · Cited by 71
Pariset, E., Malkani, S., Cekanaviciute, E., & Costes, S. V. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1820598 · Cited by 68
Peptides: Important tools for the treatment of central nervous system disorders
Malavolta, L., & Cabral, F. R. (2011) · Neuropeptides · doi:10.1016/j.npep.2011.03.001 · Cited by 66
Motor neuron trophic factors: Therapeutic use in ALS?
Gould, T. W., & Oppenheim, R. W. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.10.003 · Cited by 65
IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases
Ayadi, A. E., Zigmond, M. J., & Smith, A. D. (2016) · Experimental Brain Research · doi:10.1007/s00221-016-4572-1 · Cited by 64
Neuregulin‐1‐β1 enters brain and spinal cord by receptor‐mediated transport
Kastin, A. J., Akerstrom, V. L., & Pan, W. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02224.x · Cited by 63
Self-citationYu, Y., Kastin, A. J., & Pan, W. (2006) · Endocrinology · doi:10.1210/en.2006-0020 · Cited by 60
Self-citationThe Insulin‐like Growth Factor System in Multiple Sclerosis
Chesik, D., Wilczak, N., & Keyser, J. D. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79009-8 · Cited by 57
Hertze, J., Nägga, K., Minthon, L., & Hansson, O. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-64 · Cited by 57
Hayes, C. A., Valcarcel‐Ares, M. N., & Ashpole, N. M. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211000894 · Cited by 57
Ge, L., Liu, S., Rubin, L., Lazarovici, P., & Zheng, W. (2022) · Cells · doi:10.3390/cells11040666 · Cited by 54
Bellar, D. M., Glickman, E. L., Juvancic-Heltzel, J. A., & Gunstad, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.023 · Cited by 53
Sohrabji, F., & Williams, M. H. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12059 · Cited by 53
Wang, J., Tang, Y., Zhang, W., Zhao, H., Runjun, W., Yan, Y., Xu, L., & Li, P. (2013) · FEBS Journal · doi:10.1111/febs.12359 · Cited by 51
Bot, M., Milaneschi, Y., Penninx, B. W. J. H., & Drent, M. L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.028 · Cited by 50
“Third, although peripheral IGF-I can cross the lood brain barrier, and has some central actions (Armstrong et al., 000; Pan and Kastin, 2000), we can only speculate on whether lasma IGF-I differences also reflect differences in brain IGF-I levels, dding further complexity to the discussion of potential mechaisms.”
Growth Hormone Deficiency Following Traumatic Brain Injury
Kgosidialwa, O., Hakami, O., Zia-Ul-Hussnain, H. M., & Agha, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133323 · Cited by 48
Pan, W., Cain, C. M., Yu, Y., & Kastin, A. J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.02.006 · Cited by 48
Self-citationRejdak, K., Sienkiewicz‐Jarosz, H., Bieńkowski, P., & Álvarez, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21960 · Cited by 47
Hosback, S., Hardiman, O. M., Nolan, C. M., Doyle, M., Gorman, G. S., Lynch, C. M., O’Toole, O., & Jakeman, P. M. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.06.002 · Cited by 46
Sonntag, W. E., Bennett, C., Ingram, R., Donahue, A., Ingraham, J., Chen, H., Moore, T., Brunso-Bechtold, J. K., & Riddle, D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00012.2006 · Cited by 42
Kastin, A. J., & Pan, W. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705423 · Cited by 42
Self-citationConover, C. A., & Oxvig, C. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae029 · Cited by 39
Kim, Y., Li, E., & Park, S. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.702821 · Cited by 39
Tolbert, D. L., & Clark, B. R. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00172-9 · Cited by 39
Genetic engineering of IgG-glucuronidase fusion proteins
Boado, R. J., & Pardridge, W. M. (2010) · Journal of Drug Targeting · doi:10.3109/10611860903353362 · Cited by 37
Geyter, D. D., Smedt, A. D., Stoop, W., Keyser, J. D., & Kooijman, R. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12550 · Cited by 37
Rohrmann, S., Linseisen, J., Becker, S., Allen, N. E., Schlehofer, B., Overvad, K., Olsen, A., Tjønneland, A. M., Melin, B. S., Lund, E., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0179 · Cited by 37
Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review
Mitchell, A. K., Bliss, R. R., & Church, F. (2024) · Biomolecules · doi:10.3390/biom14101241 · Cited by 36
Why study transport of peptides and proteins at the neurovascular interface.
Pan, W., & Kastin, A. (2004) · Brain research. Brain research reviews · doi:10.1016/j.brainresrev.2004.04.006 · Cited by 34
Self-citationCunha‐Filho, J. S., Lemos, N. A., Freitas, F. M., Kiefer, K., Faller, M., & Passos, E. P. (2003) · Human Reproduction · doi:10.1093/humrep/deg077 · Cited by 34
Impact of Long-Term HFD Intake on the Peripheral and Central IGF System in Male and Female Mice
Guerra-Cantera, S., Frago, L. M., Jiménez‐Hernáiz, M., Ros, P., Freire‐Regatillo, A., Barrios, V., Argente, J., & Chowen, J. A. (2020) · Metabolites · doi:10.3390/metabo10110462 · Cited by 34
The Role of the Somatotrophic Axis in Neuroprotection and Neuroregeneration of the Addictive Brain
Nyberg, F. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88014-8 · Cited by 33
Adams, M. M., Forbes, M. E., Linville, M. C., Riddle, D. R., Sonntag, W. E., & Brunso‐Bechtold, J. K. (2009) · Growth Factors · doi:10.1080/08977190902863639 · Cited by 33
Vaes, J. E. G., Brandt, M. J. V., Wanders, N., Benders, M. J. N. L., de Theije, C. G. M., Gressèns, P., & Nijboer, C. H. A. (2020) · Glia · doi:10.1002/glia.23939 · Cited by 33
Vascular Endothelial Growth Factor and Other Angioglioneurins
Lafuente, J. V., Ortuzar, N., Bengoetxea, H., Bulnes, S., & Argandoña, E. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00012-0 · Cited by 32
Kouroupi, G., Lavdas, A. Α., Gaitanou, M., Thomaidou, D., Stylianopoulou, F., & Matsas, R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06939.x · Cited by 30
Effects of cell-type specific leptin receptor mutation on leptin transport across the BBB
Hsuchou, H., Kastin, A. J., Tu, H., Markadakis, E. N., Stone, K. P., Wang, Y., Heymsfield, S. B., Chua, S. C., Obici, S., Magrisso, I. J., et al. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.011 · Cited by 28
Self-citationInsulin-like growth factor-1 in plasma and brain: regulation in health and disease
Sievers, C., Schneider, H. J., & Stalla, G. K. (2007) · Frontiers in bioscience · doi:10.2741/2662 · Cited by 27
Insulin-Like Growth Factor Delivery Across the Blood-Brain Barrier
Riikonen, R. (2006) · Chemotherapy · doi:10.1159/000095957 · Cited by 27
Rossman, I. T., Lin, L., Morgan, K. M., DiGiovine, M. P., Buskirk, E. K. V., Kamdar, S., Millonig, J. H., & DiCicco-Bloom, E. M. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-9 · Cited by 27
Glucose signaling in the brain and periphery to memory
Hossain, M. S., Oomura, Y., Fujino, T., & Akashi, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.018 · Cited by 26
Corbo, M., Lunetta, C., Magni, P., Dozio, E., Ruscica, M., Adobbati, L., & Silani, V. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02815.x · Cited by 26
Wang, Y., Huang, M., Jiao, J., Wu, Y., Ouyang, T., Huang, J., Liu, S.-S., & Li, C.-L. (2014) · Medical Oncology · doi:10.1007/s12032-014-0921-8 · Cited by 24
Strategies to create a regenerating environment for the injured spinal cord.
Xiang, S., Pan, W., & Kastin, A. (2005) · Current pharmaceutical design · doi:10.2174/1381612053507431 · Cited by 24
Self-citationFitzgerald, G. S., Chuchta, T. G., & McNay, E. C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14160 · Cited by 22
Chang, H.-C., Yang, Y., Wang, P. S., Kuo, C., & Wang, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064015 · Cited by 22
Pan, W., & Kastin, A. J. (2004) · Elsevier eBooks · doi:10.1016/b978-012639011-7/50024-3 · Cited by 21
Self-citationBeyond appetite: Acylated ghrelin as a learning, memory and fear behavior-modulating hormone
Reich, N., & Hölscher, C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104952 · Cited by 21
Doulah, A., Rohani, A. H., Khaksari, M., Motamedi, F., Farbood, Y., Badavi, M., Malek, M., & Sarkaki, A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.016 · Cited by 20
Effects of Insulin-Like Growth Factor-1 (IGF-1) and Amifostine in Spinal Cord Reirradiation
Nieder, C., Price, R. E., Rivera, B., Andratschke, N. H., & Ang, K. K. (2005) · Strahlentherapie und Onkologie · doi:10.1007/s00066-005-1464-x · Cited by 19
Bálint, F., Csillag, V., Vastagh, C., Liposits, Z., & Farkas, I. (2020) · Neuroendocrinology · doi:10.1159/000514043 · Cited by 18
Evidence for an alternative insulin transporter at the blood-brain barrier
Banks, W. A., Noonan, C., & Rhea, E. M. (2022) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2022.12.100 · Cited by 17
Hayes, C. A., Wilson, D., Leon, M. A. D., Mustapha, M. J., Morales, S., Odden, M. C., & Ashpole, N. M. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101161 · Cited by 17
Cioana, M., Michalski, B., & Fahnestock, M. L. (2020) · Autism Research · doi:10.1002/aur.2291 · Cited by 17
Caloric restricted male rats demonstrate fewer synapses in layer 2 of sensorimotor cortex
Shi, L., Poe, B., Linville, M. C., Sonntag, W. E., & Brunso‐Bechtold, J. K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02249-7 · Cited by 16
Fergani, A., Eschbach, J., Oudart, H., Larmet, Y., Schwalenstöcker, B., Ludolph, A. C., Loeffler, J., & Dupuis, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-26 · Cited by 16
Cytokines Interact with the Blood‐Brain Barrier
Pan, W., Xiang, S., Tu, H., & Kastin, A. J. (2006) · Wiley eBooks · doi:10.1002/9783527611225.ch11 · Cited by 16
Self-citationHuhtala, T., Rytkönen, J., Jalanko, A., Kaasalainen, M. H., Salonen, J., Riikonen, R., & Närvänen, A. T. O. (2012) · Journal of Drug Delivery · doi:10.1155/2012/626417 · Cited by 16
Reijnders, C., Koster, J. G., & van Buul-Offers, S. C. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820445 · Cited by 16
Saturable Leptin Transport Across the BBB Persists in EAE Mice
Hsuchou, H., Mishra, P. K., Kastin, A. J., Wu, X., Wang, Y., Ouyang, S., & Pan, W. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9993-8 · Cited by 15
Self-citationTargeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection
Maïza, A., Hamoudi, R., & Mabondzo, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105449 · Cited by 13
Growth Hormone and Insulin-Like Growth Factor I: Effects on the Brain
Laron, Z. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00078-4 · Cited by 13
Montero, A.-S., Aliouat, I., Ribon, M., Canney, M. S., Goldwirt, L., Mourah, S., Berriat, F., Lobsiger, C. S., Pradat, P., Salachas, F., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105235 · Cited by 13
Miller, A. H., Howe, H. B., Krause, B. M., Friedle, S. A., Banks, M. I., Perkins, B. D., & Wolman, M. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0061-18.2018 · Cited by 13
Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma
Bouchnita, A., & Volpert, V. A. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111652 · Cited by 11
Compromised IGF signaling causes caspase-6 activation in Huntington disease
Skotte, N. H., Pouladi, M. A., Ehrnhoefer, D. E., Huynh, K., Qiu, X., Nielsen, S. M. B., Nielsen, T. T., Nørremølle, A., & Hayden, M. R. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113396 · Cited by 11
Insulin and the blood–brain barrier
Rhea, E. M., & Banks, W. A. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.02.002 · Cited by 10
Metadata
- Authors
- Pan, W., & Kastin, A. J.
- Affiliations
- Tulane University (US)
- ORCID
- Pan, Weihong
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 72
- Issue
- 3
- Pages
- 171-178
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2093730240
- Cited by
- 185
- References
- 24
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 29 · 2023: 13 · 2022: 7 · 2021: 4 · 2020: 10 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 2 · 2014: 6 · 2013: 11 · 2012: 9
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-54880)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- insulin-like growth factor I, blood-brain barrier, IGF binding proteins, protein binding, saturable transport, neuroprotection
- MeSH terms
- Animals, Biological Transport, Blood Chemical Analysis, Blood Circulation Time, Blood-Brain Barrier, Brain, Carrier Proteins, Cerebrovascular Circulation, Chromatography, High Pressure Liquid, Insulin-Like Growth Factor I, Iodine Radioisotopes, Male, Mice, Inbred ICR, Peptide Fragments, Radionuclide Imaging, Regression Analysis, Spinal Cord, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.